Ino Y - Search Results

1

Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer.

Yanagihara K, Takigahira M, Tanaka H, Komatsu T, Fukumoto H, Koizumi F, Nishio K, Ochiya T, Ino Y, Hirohashi S. Yanagihara K, et al. Among authors: ino y. Cancer Sci. 2005 Jun;96(6):323-32. doi: 10.1111/j.1349-7006.2005.00054.x. Cancer Sci. 2005. PMID: 15958054 Free PMC article.

2

Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice.

Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, Toge T, Sugano K, Hirohashi S. Yanagihara K, et al. Among authors: ino y. Cancer Sci. 2004 Jul;95(7):575-82. doi: 10.1111/j.1349-7006.2004.tb02489.x. Cancer Sci. 2004. PMID: 15245593 Free PMC article.

3

Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.

Nam JS, Ino Y, Sakamoto M, Hirohashi S. Nam JS, et al. Among authors: ino y. Clin Cancer Res. 2002 Jul;8(7):2430-6. Clin Cancer Res. 2002. PMID: 12114449

4

Ras farnesylation inhibitor FTI-277 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.

Nam JS, Ino Y, Sakamoto M, Hirohashi S. Nam JS, et al. Among authors: ino y. Jpn J Cancer Res. 2002 Sep;93(9):1020-8. doi: 10.1111/j.1349-7006.2002.tb02479.x. Jpn J Cancer Res. 2002. PMID: 12359056 Free PMC article.

5

Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas.

Takamura M, Sakamoto M, Ino Y, Shimamura T, Ichida T, Asakura H, Hirohashi S. Takamura M, et al. Among authors: ino y. Cancer Sci. 2003 May;94(5):425-30. doi: 10.1111/j.1349-7006.2003.tb01459.x. Cancer Sci. 2003. PMID: 12824888 Free PMC article.

6

Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells.

Shimamura T, Yasuda J, Ino Y, Gotoh M, Tsuchiya A, Nakajima A, Sakamoto M, Kanai Y, Hirohashi S. Shimamura T, et al. Among authors: ino y. Cancer Res. 2004 Oct 1;64(19):6989-95. doi: 10.1158/0008-5472.CAN-04-1166. Cancer Res. 2004. PMID: 15466191

7

Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.

Nitori N, Ino Y, Nakanishi Y, Yamada T, Honda K, Yanagihara K, Kosuge T, Kanai Y, Kitajima M, Hirohashi S. Nitori N, et al. Among authors: ino y. Clin Cancer Res. 2005 Apr 1;11(7):2531-9. doi: 10.1158/1078-0432.CCR-04-0866. Clin Cancer Res. 2005. PMID: 15814630

8

Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice.

Yamada T, Mori Y, Hayashi R, Takada M, Ino Y, Naishiro Y, Kondo T, Hirohashi S. Yamada T, et al. Among authors: ino y. Cancer Res. 2003 Mar 1;63(5):895-901. Cancer Res. 2003. PMID: 12615699

9

5-aza-2'-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis.

Nam JS, Ino Y, Kanai Y, Sakamoto M, Hirohashi S. Nam JS, et al. Among authors: ino y. Clin Exp Metastasis. 2004;21(1):49-56. doi: 10.1023/b:clin.0000017180.19881.c1. Clin Exp Metastasis. 2004. PMID: 15065602

10

Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.

Shimamura T, Sakamoto M, Ino Y, Shimada K, Kosuge T, Sato Y, Tanaka K, Sekihara H, Hirohashi S. Shimamura T, et al. Among authors: ino y. Clin Cancer Res. 2002 Aug;8(8):2570-5. Clin Cancer Res. 2002. PMID: 12171885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters